PPARA and cancer: Eight pathways (e.g., the proteasome, PPAR signaling, cancer, and zeatin biosynthesis pathways) were more abundant in the MP group, while two other pathways (e.g., type II polyketide product biosynthesis and stilbenoid, diarylheptanoid and gingerol biosynthesis) were more abundant in the LP group.